Industry Voice 2
Monty Keast of Ultragenyx on bringing novel therapies to underserved patient communities and why rare diseases must be treated differently than other, more common conditions. For Patient Voice.
Monty Keast of Ultragenyx on bringing novel therapies to underserved patient communities and why rare diseases must be treated differently than other, more common conditions. For Patient Voice.